Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV CONCLUSIONS: These data support the use of BLV in patients infected with any HBV/HDV … ← Beyond the Operating Room: Exploring Gender Bias in Leadership Positions in German Plastic Surgery Rebound or Cage Escape? The Role of the Rebound Barrier for the Reactivity of Non-heme High-valent FeIV=O species →